007127787 | PUO | 39865970 | | 4980731 | 7/8/2006 12:00:00 AM | shortness of breath | | DIS | Admission Date: 7/1/2006 Report Status: 

Discharge Date: 2/20/2006 ****** FINAL DISCHARGE ORDERS ****** GLEMBOCKI , SANDY 490-16-32-7 Kan Own Service: MED DISCHARGE PATIENT ON: 10/10/06 AT 11:00 AM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: DELMENDO , CRISTINE V. , M.D. CODE STATUS: Full code DISPOSITION: Home w/ services DISCHARGE MEDICATIONS: ACETYLSALICYLIC ACID 81 MG PO DAILY Override Notice: Override added on 3/28/06 by YEAGLEY , MA GLADIS NUBIA , M.D. on order for COUMADIN PO ( ref # 352626747 ) POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN Reason for override: aware ATENOLOL 75 MG PO DAILY LIPITOR ( ATORVASTATIN ) 20 MG PO DAILY Alert overridden: Override added on 3/25/06 by : POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; ATORVASTATIN CALCIUM Reason for override: will monitor LOVENOX ( ENOXAPARIN ) 90 MG SC BID X 5 Days Starting on 10/25 LASIX ( FUROSEMIDE ) 40 MG PO DAILY LANTUS ( INSULIN GLARGINE ) 60 UNITS SC DAILY Starting Today January LISINOPRIL 5 MG PO DAILY Alert overridden: Override added on 3/28/06 by YEAGLEY , MA GLADIS NUBIA , M.D. POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; LISINOPRIL POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; LISINOPRIL Reason for override: watch GLUCOPHAGE XR ( METFORMIN EXTENDED RELEASE ) 500 MG PO QAM Number of Doses Required ( approximate ): 1 COUMADIN ( WARFARIN SODIUM ) 6 MG PO QPM Starting ROUTINE , 20:00 ( Standard Admin Time ) Food/Drug Interaction Instruction No high Vitamin-K containing foods Alert overridden: Override added on 3/28/06 by YEAGLEY , MA GLADIS NUBIA , M.D. POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; WARFARIN Reason for override: aware DIET: House / Low chol/low sat. 
fat DIET: House / ADA 2100 cals/dy DIET: 2 gram Sodium ACTIVITY: Walking as tolerated FOLLOW UP APPOINTMENT( S ): Dr. Raspotnik Please call for appointment next week , Dr. Fiermonte next available , Arrange INR to be drawn on 6/27/06 with f/u INR's to be drawn every 3 days. 
INR's will be followed by Dr. Raspotnik ALLERGY: NKA ADMIT DIAGNOSIS: chest pain PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) shortness of breath OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay DM type II S/p cholecystectomy Right DVT hypercholesterolemia s/p chole ( S/P cholecystectomy ) uterine prolapse , s/p TAH ( uterine prolapse ) htn ( hypertension ) s/p small bowel resection cad , s/p IMI and PTCA w/ stents x2 ( coronary artery disease ) OPERATIONS AND PROCEDURES: None OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) MIBI BRIEF RESUME OF HOSPITAL COURSE: CC: chest pain , diaphoresis HPI: 66F CAd , s/p MI x3 , s/p stents , PVD , DM , woke at 1am with SSCP , nausea , diaphoresis. 
Called EMS , pain lasted &lt;30min , got asa , ntg. 
IN ED was pain free. 
Recent social stressors as daughter with high risk pregnancy. 
Ruled out x 3 enzymes. 
PMH: CAD , MI , RCA stent x 2 1999 , OM stent at DIH , DM , PVD , lipids , CCY , SB resection , R DVT , antiphospholipid , prothrombin gene mutation , TAH STATUS: A+O , jvp 6 cm , RRR , clear lungs , no edema HOSPITAL COURSE: The patient was admitted to GMS Mont for further work up of her shortness of breath and chest pain for rule out of myocardial infarction. 
The patient remained pain free throughout her hospital course and denied any shortness of breath , increased lower extremity swelling , nausea , diaphoresis or other complaints. 
She had three sets of cardiac enzymes return negative while in house. 
Her EKG showed evidence of old TWI with some minimal flattening of T waves in II and V3. 
She had CXR showing no acute cardiopulmonary process. 
She had adeno MIBI done on 12/10 showing no evidence of EKG changes or symptoms with HR 51-&gt;71 and BP 124-&gt;70. 
Final reading showed moderate ischemia in inferiolateral wall in L circumflex territory with EF 59%. 
Her cardiologist Dr. Fiermonte was called and recommended cath. 
She had a cardiac catheterization on 10/25 which showed only distal disease and was not intervened upon. 
She will continue with her medical management. 
She was noted to have INR of 1.4 and was taking coumadin ?non-compliant at home. 
With her history of hypercoaguable disorders , she was started on lovenox and coumadin 6mg and to continue lovenox for at least 5 days until INR is therapeutic. 
She will have VNA come to check her INR in two days and again next week and then send information to her PCP Dr. Raspotnik for further follow up andrecommendations. 
ADDITIONAL COMMENTS: Ux A Verden VNA - please draw INR on 6/27/06 and 9/23/2006 . 
Call INR results into PCP Dr. Raspotnik 422-797-9947. 
Goal INR 2-3. 
Lovenox may be discontinued when INR is 2-3. 
If lovenox refills are needed , Contact Dr. Raspotnik . 
Patient should have INR checked every 3 days until she is on a stable dose of coumadin. 
DISCHARGE CONDITION: Stable TO DO/PLAN: 1. VNA will draw your blood on Tuesday 9/29 2. Continue taking all of your medications , including coumadin. 
3. Take Lovenox injections until told to stop by your doctor. 
No dictated summary ENTERED BY: RUNNING , HYON , M.D. ( QB45 ) 10/10/06 @ 10:40 AM ****** END OF DISCHARGE ORDERS ******